Rashid Khairi
Endocrinology, Diabetes & Metabolism · Indianapolis, INNPI 1578586681
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in IN, where the typical reported total is $1,569.
Across 156 payments — averaging $13.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$250
- Novo Nordisk$236
- AstraZeneca$221
- Antares Pharma, Inc.$178
- Mannkind Corporation$165
- Sanofi-aventis U.S. LLC$153
- plus $844 from 18 others
What the payments were for
- Food & beverage$2,039100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 19 | $250 |
| Novo Nordisk | 23 | $236 |
| AstraZeneca(2 entities) | 13 | $221 |
| Antares Pharma, Inc. | 14 | $178 |
| Mannkind Corporation | 11 | $165 |
| Sanofi-aventis U.S. LLC | 13 | $153 |
| Corcept Therapeutics | 9 | $134 |
| Lilly USA, LLC | 12 | $132 |
| Shire North American Group Inc | 7 | $115 |
| Amgen | 6 | $79 |
| Vivus LLC | 6 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Senseonics, Incorporated | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| IBSA Pharma Inc. | 2 | $32 |
| Medtronic | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $27 |
| Eisai Inc. | 2 | $25 |
| Lifescan, Inc. | 2 | $23 |
| AbbVie | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Companion Medical, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$2,047 in reported general payments places this provider in the 50th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.
See all endocrinology, diabetes & metabolism providers in Indiana →
Other endocrinology, diabetes & metabolism in Indianapolis
- Ernest AsamoahIndianapolis$959K
- Hisham AllababidiIndianapolis$195K
- Michael EconsIndianapolis$74K
- Carmella Evans-MolinaIndianapolis$55K
- Manuel Bello SeguraIndianapolis$44K
- Moazzam HabibIndianapolis$29K
- James EdmondsonIndianapolis$10K
- James ScheidlerIndianapolis$8K
- Cary MariashIndianapolis$6K
- Jayender ChintaparthiIndianapolis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.